Lamotrigin und die Haut.

We report a patient with personality disorder and depression who developed a reversible macular rash 10 days after starting lamotrigine (LTG). We discuss the safety profile of LTG, risk factors for adverse reactions of the skin, the management of risk reduction of LTG - induced skin reactions and the possibility of a controlled reexpostion of patients with benign LTG - associated rash. [ABSTRACT FROM AUTHOR]